Ann: Proposed issue of Securities - ZLD, page-4

You cant. Probably shouldnt buy any shares.

this is a spec a punt ... there is no revenue and modelling has not been announced.

options are contingent on sales in the millions.

zelira now has 10mill in cash and all the leg work to clinically validate a world first cannibas drug, purchased a successful autism drug, built team in the US, secured manufacturing, distribution .... and again with all that work done and 10mill in the bank is about to execute a global launch strategy which puts 5 proprietary products into the Australian and US market.

one of those products a world first clinically validated cannibas alternative to treat insomnia ... launched into a multi billion dollar market.

another one of those products is a prooven and successful alternative drug to treat autism.

if options are exercised then that means Zelira has launched drugs globally and HAS generated revenue in the millions.

even if revenue targets are not met and options not matured then you still have the same go to market strategies, dropping disruptive products, into large markets, years in the making, with 10m in cash ... happening in the next few months.

it remains a risk a punt a spec but the ingredients look better than they have in a long long time.

feel free to wait and purchase what you can on market.